ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

医学 社区获得性肺炎 麻醉学 止痛药 重症监护医学 肺炎 病理 内科学
作者
Ignacio Martín‐Loeches,Antoni Torres,Blin Nagavci,Stefano Aliberti,Massimo M. Antonelli,Matteo Bassetti,Lieuwe D. J. Bos,James Duncan Chalmers,Lennie P. G. Derde,Jan J. De Waele,José Garnacho‐Montero,Marin H. Kollef,Carlos M. Luna,Rosario Menéndez,Michael S. Niederman,Dmitry Ponomarev,Marcos I. Restrepo,David Rigau Comas,Marcus Josephus Schultz,Emmanuel Weiss
出处
期刊:Intensive Care Medicine [Springer Science+Business Media]
卷期号:49 (6): 615-632 被引量:402
标识
DOI:10.1007/s00134-023-07033-8
摘要

Severe community-acquired pneumonia (sCAP) is associated with high morbidity and mortality, and whilst European and non-European guidelines are available for community-acquired pneumonia, there are no specific guidelines for sCAP. The European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and Latin American Thoracic Association (ALAT) launched a task force to develop the first international guidelines for sCAP. The panel comprised a total of 18 European and four non-European experts, as well as two methodologists. Eight clinical questions for sCAP diagnosis and treatment were chosen to be addressed. Systematic literature searches were performed in several databases. Meta-analyses were performed for evidence synthesis, whenever possible. The quality of evidence was assessed with GRADE (Grading of Recommendations, Assessment, Development and Evaluation). Evidence to Decision frameworks were used to decide on the direction and strength of recommendations. Recommendations issued were related to diagnosis, antibiotics, organ support, biomarkers and co-adjuvant therapy. After considering the confidence in effect estimates, the importance of outcomes studied, desirable and undesirable consequences of treatment, cost, feasibility, acceptability of the intervention and implications to health equity, recommendations were made for or against specific treatment interventions. In these international guidelines, ERS, ESICM, ESCMID, and ALAT provide evidence-based clinical practice recommendations for diagnosis, empirical treatment, and antibiotic therapy for sCAP, following the GRADE approach. Furthermore, current knowledge gaps have been highlighted and recommendations for future research have been made.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hushan53发布了新的文献求助10
刚刚
小M完成签到,获得积分20
1秒前
平淡语薇发布了新的文献求助10
1秒前
东巷那只鼠完成签到,获得积分10
1秒前
1秒前
nuan77发布了新的文献求助10
1秒前
嘉博学长发布了新的文献求助10
2秒前
雷穗天发布了新的文献求助10
2秒前
你好吖发布了新的文献求助10
2秒前
weber完成签到,获得积分10
2秒前
3秒前
chengzi发布了新的文献求助10
3秒前
xiaoyang完成签到 ,获得积分10
3秒前
3秒前
qiqiqiqiqi发布了新的文献求助10
3秒前
JJ完成签到,获得积分10
4秒前
molihuakai的应助被婧婧采纳,获得10
4秒前
Dbwww发布了新的文献求助10
4秒前
4秒前
4秒前
4秒前
ayuelei完成签到,获得积分10
4秒前
4秒前
英俊的铭的应助被DrHyuan采纳,获得10
5秒前
酷波er的应助被so采纳,获得10
5秒前
404发布了新的文献求助10
5秒前
辛勤电源发布了新的文献求助10
6秒前
6秒前
英姑的应助被嘉博学长采纳,获得10
6秒前
郁乾完成签到,获得积分0
6秒前
冷傲凝阳发布了新的文献求助10
6秒前
丘比特的应助被Anaturez采纳,获得10
6秒前
田様的应助被愉快雪曼采纳,获得10
6秒前
h777完成签到,获得积分20
6秒前
Hello的应助被白晨采纳,获得10
7秒前
7秒前
7秒前
lqy1214发布了新的文献求助10
7秒前
伶俐的玫瑰完成签到,获得积分10
7秒前
传奇3的应助被滴滴答答采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8170166
求助须知:如何正确求助?哪些是违规求助? 9563213
关于积分的说明 21768986
捐赠科研通 7761665
什么是DOI,文献DOI怎么找? 3430630
关于科研通互助平台的介绍 2554458
邀请新用户注册赠送积分活动 2475393